A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia

Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies

(2012) W. Barcellini et al.   BLOOD

Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia

(2012) V. L. Patel et al.   BLOOD

Evidence-based focused review of the treatment of idiopathic warm immune hemolytic anemia in adults

(2011) M. Crowther et al.   BLOOD

Rituximab therapy for autoimmune haematological diseases

(2011) Wilma Barcellini et al.   European Journal of Internal Medicine

Assessment of flares in lupus patients enrolled in a phase II/III study of rituximab (EXPLORER)

(2011) JT Merrill et al.   LUPUS

How I treat autoimmune hemolytic anemias in adults

(2010) K. Lechner et al.   BLOOD

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

(2009) K. R. Carson et al.   BLOOD

Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study

(2009) D. Dierickx et al.   JOURNAL OF INTERNAL MEDICINE

Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: Retrospective analysis of 27 cases

(2008) Guillaume Bussone et al.   AMERICAN JOURNAL OF HEMATOLOGY

Rituximab in the treatment of autoimmune haematological disorders

(2008) Bernadette Garvey   BRITISH JOURNAL OF HAEMATOLOGY

Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results

(2008) Marta Medeot et al.   EUROPEAN JOURNAL OF HAEMATOLOGY